Nicolas ANDRE
Assistance Publique - Hôpitaux de Marseille · CHU La Timone · Hôpital La Timone, Marseille, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nicolas ANDRE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:51 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06485908 · Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and EpendymomaAssistance Publique Hopitaux De Marseille · recruiting · Medulloblastoma, Ependymoma · principal investigator
- Ph1/Ph2NCT03585465 · Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsCentre Oscar Lambret · terminated · Childhood Solid Tumor · study director
- Ph2NCT02197637 · Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade GliomaCentre Oscar Lambret · completed · Low-Grade Glioma · principal investigator
- Ph1NCT02115074 · Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCentre Oscar Lambret · completed · Glioma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in medulloblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 13:51 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.Neuro Oncol · 202368 citationsRCR 5.2
- 61 citationsRCR 2.0
- Pilot study of a pediatric metronomic 4-drug regimen.Oncotarget · 201158 citationsRCR 1.6
- Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.JAMA Oncol · 202345 citationsRCR 4.1
- Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.Neuro Oncol · 202135 citationsRCR 2.1
- Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.Clin Cancer Res · 202416 citationsRCR 2.0